The effects of benzodiazepines in pregnancy

Acta Neurologica Belgica

Volumn 110, Issue 2, 2010, Pages 163-167

  Leppée, Marcel ^a   Culig, Josip ^b   Eric, Mirela ^c   Sijanovic, Sinisa ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

^d UNIVERSITY HOSPITAL OSIJEK   (Croatia)

Author keywords

Anxiolytics; Benzo diazepines; Diazepam; Pregnancy

Indexed keywords

ANALGESIC AGENT; ANXIOLYTIC AGENT; ATENOLOL; BENZODIAZEPINE; CEFALEXIN; DIAZEPAM; DYDROGESTERONE; IRON; MINERAL; NYSTATIN; OXYTETRACYCLINE; RITODRINE; VITAMIN;

ARTICLE; CONGENITAL HEART MALFORMATION; CROATIA; FEMALE; FOOD AND DRUG ADMINISTRATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; UROGENITAL TRACT MALFORMATION; ABNORMALITIES, DRUG-INDUCED; ANXIETY; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG THERAPY; STOMACH DISEASE;

ABNORMALITIES, DRUG-INDUCED; ANTI-ANXIETY AGENTS; ANXIETY; CARDIOVASCULAR DISEASES; DIAZEPAM; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; STOMACH DISEASES;

EID: 77955970364     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Austin MP, Mitchell PB. Psychotropic medications in pregnant women: treatment dilemmas. Med J Aust. 1998;169:428-431.
2. Bérard A, Ramos E. Antidepressants and pregnancy: risks and benefits for the mother and child. Medecine Sciences, 2007;23:957-960.
3. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 5th ed., Baltimore, Williams and Wilkins, 1998.
4. Campagne DM. Fact: antidepressants and anxiolytics are not safe during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2007;135:145-148.
5. Chaudhuri G, Giacoia GP, Yaffe SY. Drug development for pregnancy. In: "Drug development for women". Ragavan VV, ed. John Wiley and Sons, Chichester: 1998: 213-234.
6. Dolovich LR, Addis A, Vaillancourt RJ, Power BJ, Koren G. et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 1998;317: 839-843.
7. Eric M. Research of teratogenic effects of medicines on embryo. MS thesis. School of Medicine, University of Novi Sad, Novi Sad, 2004.
8. Culig J, Leppée M, Stimac D, Kuvacic I, Pulanic- Klepac T. et al. Cross-sectional study of drug use in pregnancy. Lijec vjesn. 2007;129:253-259.
9. Eric M, Sabo A. Teratogenicity of antibacterial agents. Coll Antropol. 2008;32:919-925.
10. Freedman MJ, Polifka EJ. The effects of drugs on the fetus and nursing infant: a handbook for health care professionals. Johns Hopkins University Press, Baltimore; 1996.
11. Freedman MJ, Polifka EJ. Teratogenic effects of drugs: a resource for clinicians. Johns Hopkins University Press, Baltimore; 2000.
12. Freeman MP, Hibbeln JR, Wisner KL, Watchman M, Gelenberg AJ. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatrica. 2006;18:21-24.
13. Regier DA, Narrow WE, Rae DS. The epidemiology of anxiety disorders: the Epidemiologic Catchment Area (ECA) experience. J Psychiatr Res, 1990;2: 3-14.
14. Altshuler LL, Hendrick V, Cohen LS. Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry, 1998; 59 (suppl 2):29-33.
15. Rubinchik MS, Kablinger SA, Gardner SJ. Medications for panic disorder and generalized anxiety disorder during pregnancy. Primary Care Companion to The Journal of Clinical Psychiatry, 2005;7:100-105.
16. Tognoni G, Liberati A, Pello L, Sasanelli F, Spagnoli A. Drug utilization studies and epidemiology. Rev Epidemiol Sante Publique. 1983;31:59-71.
17. Gentile S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf, 2005;28: 137-152.
18. Gidai J, Acs N, Banhidy F, Czeizel AE. No association found between use of very large doses of dia - zepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring. Toxicol Ind Health. 2008;24:29-39.
19. Koren G. Maternal-fetal toxicology: a clinician's guide. 3rd ed. Marcel Dekker, New York: 2001.
20. Leppée M. Drugs in pregnancy. PhD thesis. School of Medicine, Josip Juraj Strossmayer University, Osijek ; 2008.
21. Altshuler LL, Cohen L, Szuba MP. et al. Pharmacologic management of psychiatric illness during pregnancy : dilemmas and guidelines. Am J Psychiatry. 1996;153:592-606.
22. Rubinchik SM, Kablinger AS, Gardner JS. Medication for panic disorder and generalized anxiety disorder during pregnancy. Prim Care Companion J Clin Psychiytry. 2005;7:100-5.
23. Addis A, Dolovich LR., Einarson TR., Koren G, Motherisk. Meta-analysis, Canadian Health Net - work . March 2000.
24. McGrath C, Buist A, Norman TR. Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus. Drug Saf. 1999;20:171-186.
25. Nesse RM, Zamorski MA. Anxiety disorders in primary care. In: Knesper DJ, Riba MB, Schwenk TL, eds. Primary care psychiatry. Saunders, Philadelphia; 1997:132-162.
26. Shepard TH. Teratogenicity of therapeutic agents. Curr Probl Pediatr. 1979;10:1-42.
27. Goldberg HL. Psychotropic drugs in pregnancy and lactation. Int J Psychiatry Med. 1994;24:129-147